Apolipoprotein A-I (APOA1), the major protein component of high-density lipoprotein (HDL) particles, mediates reverse cholesterol transport and holds immense clinical importance regulating atherosclerosis progression. Identified in 1975, it took decades of research to reveal mechanisms underlying its pivotal cardiovascular protective effects.

ELISA kit information:

• Reactivity: Human
• Sample Type: Plasma, Tissue Homogenates, Serum, Biological Fluids
• Sensitivity: 0.188 ng/ml
• Target: APOA1, Apolipoprotein A-I, Alp-1, Brp-14, Apo-A1